Astrazeneca (AZNCF) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Astrazeneca (AZNCF) over the last 8 years, with Q4 2025 value amounting to -$2.0 billion.
- Astrazeneca's Long-Term Debt Repayments fell 4008000.0% to -$2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.0 billion, marking a year-over-year increase of 5638.44%. This contributed to the annual value of -$2.0 billion for FY2025, which is 5638.44% up from last year.
- Latest data reveals that Astrazeneca reported Long-Term Debt Repayments of -$2.0 billion as of Q4 2025, which was down 4008000.0% from -$4.0 million recorded in Q3 2025.
- Astrazeneca's Long-Term Debt Repayments' 5-year high stood at -$4.0 million during Q1 2022, with a 5-year trough of -$2.6 billion in Q2 2024.
- For the 4-year period, Astrazeneca's Long-Term Debt Repayments averaged around -$945.5 million, with its median value being -$632.5 million (2022).
- As far as peak fluctuations go, Astrazeneca's Long-Term Debt Repayments crashed by 5000000.0% in 2023, and later surged by 9980.04% in 2025.
- Astrazeneca's Long-Term Debt Repayments (Quarter) stood at -$1.3 billion in 2022, then decreased by 12.05% to -$1.4 billion in 2023, then soared by 99.64% to -$5.0 million in 2024, then crashed by 40080.0% to -$2.0 billion in 2025.
- Its last three reported values are -$2.0 billion in Q4 2025, -$4.0 million for Q3 2025, and -$12.0 million during Q2 2025.